InvestorWire NewsRoom

InvestorNewsBreaks

NewsBreak Category: Biotechnology
Friday Oct 22, 2021 - 12:35 pm

InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Identifies Market Gap, Launches ‘Desire Project’

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF), a leader in advanced proprietary technology and research for psychedelics, recently launched its “Desire Project” to address and treat female hypoactive sexual desire disorder (“HSDD”) with MDMA-assisted psychotherapy. A first-of-its-kind study, the Desire Project, is targeting HSDD, a common sexual disorder characterized by a persistent, low sexual drive with emotional distress that is not associated with an existing…

Continue Reading

Friday Oct 22, 2021 - 12:26 pm

InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Facilitating Improved Diabetes and Prediabetes Management

Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing diagnostic devices and supporting personalized lifestyle coaching programs. Its flagship product, sugarBEAT(R), is a wearable, non-invasive and flexible continuous glucose monitor designed to help people with diabetes and prediabetes manage their glucose levels. “Over 420 million people globally are currently living with diabetes, with prediabetic cases totaling almost three times that number,” reads…

Continue Reading

Friday Oct 22, 2021 - 12:16 pm

InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd.’s (NASDAQ: ANPC) Unique Platform Offering Comprehensive Blood Test Data, New Approach to Disease Screening

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, has developed the Cancer Differentiation Analysis (“CDA”) technology — a proprietary approach to detect cancerous and pre-cancerous diseases. “CDA uses the blood’s natural biophysical properties to identify cancerous environments before tumors even form. The CDA platform, in which technology is combined with protein-based biomarker tests to obtain even more comprehensive…

Continue Reading

Friday Oct 22, 2021 - 12:02 pm

InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Well Qualified to Provide Global Insight into Medical Cannabis

RYAH Group (CSE: RYAH), a connected device and big data and technology company, in a recent blog post provided insight into the cannabis medical space in Brazil, the largest South American country both in size and population, boasting a GDP per capita of $15,388. A recent article that contains excerpts from the post notes that medical cannabis in Brazil may face some steep political hurdles…

Continue Reading

Friday Oct 22, 2021 - 9:35 am

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Present at Benzinga Global Small Cap Conference

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild to moderate obstructive sleep apnea (“OSA”) and snoring, today announced that its chairman and CEO Kirk Huntsman and CFO Brad Amman will be presenting at the online Benzinga Global Small Cap Conference. The event is slated to take place from Oct. 27-28,…

Continue Reading

Wednesday Oct 20, 2021 - 3:23 pm

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Showcasing Innovations in OSA Treatment at 2021 Annual Breathing Wellness Conference

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from mild to moderate obstructive sleep apnea (“OSA”) and snoring, has announced the commencement of the 3rd-annual Breathing Wellness Conference presented by The Vivos Institute. The event is taking place at Caesars Palace in Las Vegas, Nevada, from Oct. 20-23, 2021, where dentists and medical doctors from…

Continue Reading

Tuesday Oct 19, 2021 - 1:36 pm

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS), Candid to Bring Airway and Sleep, Oral Health, Orthodontic Therapy Together in Comprehensive Solution

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from mild to moderate obstructive sleep apnea (“OSA”) and snoring, and Candid Care Co., a digital platform for oral healthcare, have announced a new collaboration. Under the partnership, the companies will seek to provide patients with a comprehensive, whole-mouth solution to diagnose and treat OSA in adult…

Continue Reading

Friday Oct 15, 2021 - 11:37 am

InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Focusing on What It Does Best

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF), a leader in advanced proprietary technology and research for psychedelics, recently released its financial results for the twelve months ended May 31, reporting on its first full year of operations since incorporation in March 2020. “The company initially began the year developing a nootropic line of functional mushrooms and supplements, in line with the rising consumer use of…

Continue Reading

Friday Oct 15, 2021 - 11:28 am

InvestorNewsBreaks – Brain Scientific Inc. (BRSF) Enabling Hospitals with Efficient EEG Testing Solution

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, is making it possible for all hospitals to perform EEG tests efficiently. Its neurotech ecosystem gives neurologists the resources they need to automate tedious tasks and focus their energy on the patient while simultaneously broadening their range of impact. With the unavailability of EEGs in emergency response vehicles and a majority…

Continue Reading

Friday Oct 15, 2021 - 11:07 am

InvestorNewsBreaks – Why Nemaura Medical Inc. (NASDAQ: NMRD) Is ‘One to Watch’

Nemaura Medical (NASDAQ: NMRD) is a medical technology company developing affordable diagnostic and digital tools for chronic disease management. Founded in 2011, the company set out to create a single platform technology to measure blood markers at the surface of the skin. Since then, it has evolved with the creation of wearable technologies and digital health care solutions that encourage and empower people to take…

Continue Reading

Wednesday Oct 13, 2021 - 10:17 am

InvestorNewsBreaks – Vivos Therapeutics Inc.’s (NASDAQ: VVOS) Guides Demonstrate Significant Reduction of Pediatric Tooth Decay in Peer-Reviewed Study

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild to moderate obstructive sleep apnea (“OSA”), today announced results from a peer-reviewed, published study by an independent dentist. The findings demonstrate a significant reduction of tooth decay in pediatric patients after undergoing treatment using the company’s FDA Class 1 registered Vivos Guide,…

Continue Reading

Tuesday Oct 12, 2021 - 11:07 am

InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Present at KSCA Psychedelics Virtual Investor Conference

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced that it will present at the KCSA Psychedelics Virtual Investor Conference at 3:00 p.m. ET on Oct. 14, 2021. The event is slated to take place virtually on Oct. 13-14, 2021. Tryp’s Chief Financial Officer Luke Hayes will provide a live overview of…

Continue Reading

Monday Oct 11, 2021 - 2:23 pm

InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Providing Reliable, Consistent Dose Administration and Monitoring Devices

RYAH Group (CSE: RYAH), a connected device and big data and technology company, offers a suite of precision intake control and management devices that provide a practical way to execute volume control guidelines safely. In a company blog post, discussed in a recent article, RYAH noted that a global task force had created three separate dosing protocols: routine administration, conservative administration and rapid administration, with…

Continue Reading

Monday Oct 11, 2021 - 2:12 pm

InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Stands Distinct in World of Cancer Prevention, Treatment

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, is a proven early thought leader and developer of multi-cancer (also called pan-cancer) ideas and technology. “AnPac Bio is one of the first companies in the world to produce major theories and methods of multi-level, multi-parameter and multi-cancer screening. The innovative technology has opened up a new field in early…

Continue Reading

Monday Oct 11, 2021 - 1:28 pm

InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Preparing for Clinical Trials Amid Growing Push for New Federally Approved Therapeutic

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) expects to soon launch a phase 2a clinical trial to determine the efficacy of its psychedelic drug candidate TRP-8802 in treating Prader-Willi Syndrome, hypothalamic obesity eating disorder resulting from removal of a brain tumor, and binge eating disorder. According to a recent article, TRP-8802 will be used in combination with psychotherapy under professional care to create the proper mindset…

Continue Reading

Monday Oct 11, 2021 - 9:35 am

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Berubicin’s Impressive Potential in Syndicated Broadcast

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today announced that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. According to the update,…

Continue Reading

Friday Oct 08, 2021 - 11:36 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Poised to Become Global Leader in Manufacture of Rare Cannabinoids

InMed Pharmaceuticals (NASDAQ: INM) recently announced it had signed a definitive agreement to acquire 100% of BayMedica Inc., a U.S.-based private company specializing in the manufacture and commercialization of rare cannabinoids. InMed CEO Eric A. Adams described the acquisition as a transformative transaction for the company as it would give InMed a breadth of synthetic cannabinoid manufacturing capabilities. “BayMedica brings unparalleled cannabinoid manufacturing expertise in…

Continue Reading

Tuesday Oct 05, 2021 - 12:18 pm

InvestorNewsBreaks – Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Plans Expansion into UK Market

Kaival Brands (NASDAQ: KAVL), the exclusive global distributor of products by Bidi(R) Vapor LLC, has announced plans to release its products into the United Kingdom. According to the company, the UK market is an ideal opportunity for Bidi Vapor's initial international rollout. The company is directing a substantial amount of time and resources on its efforts in international markets where it has full market and…

Continue Reading

Tuesday Oct 05, 2021 - 11:38 am

InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate at Upcoming LD Micro Main Event

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, has announced that it will be featured at the 14th annual LD Micro Main Event conference; the conference will be a virtual event. As part of the company’s presence at the conference, NMRD CEO Faz Chowdhury, PhD, will present an overview of…

Continue Reading

Tuesday Oct 05, 2021 - 10:22 am

InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) to Present at LD Micro Conference

RYAH Group (CSE: RYAH) today announced that its CEO Gregory Wagner will be presenting at the virtual LD Micro conference on Tuesday, Oct. 12, 2021. The interactive online event is expected to give Wagner an opportunity to highlight RYAH's mission and approach for the audience of investment community professionals and existing shareholders. Wagner’s presentation is scheduled to begin at 10:30 a.m. ET, where he will…

Continue Reading

Monday Oct 04, 2021 - 2:29 pm

InvestorNewsBreaks – Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Secures $8M in Underwritten Public Offering

Kaival Brands (NASDAQ: KAVL), the exclusive global distributor of products manufactured by Bidi Vapor LLC, has closed its previously announced underwritten public offering of 4,700,000 shares of its common stock and accompanying warrants to purchase up to 3,525,000 shares of common stock. According to the update, Kaival Brands secured approximately $8.0 million in gross proceeds with each share of common stock sold together with 0.75…

Continue Reading

Monday Oct 04, 2021 - 10:02 am

InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Achieves Several Key Milestones in 2021

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF), a leader in advanced proprietary technology and research for psychedelics, has so far reached several key milestones in 2021. According to a recent article, these include: “raising $23 million in a bought deal short form prospectus public offering that closed in February this year. On the technology side, MCURF launched the minimum viable product (‘MVP’) of iSTRYM in…

Continue Reading

Monday Oct 04, 2021 - 9:42 am

InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Study Results Confirming Correlation Between CDA Score, Risk of Cancer

AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, has reached a significant milestone and positive result in its general-population, cancer-risk assessment tests and subsequent follow-up study. At the end of September 2021, healthcare providers confirmed more than 2,000 cancer, precancer and disease cases. According to the announcements, those cases include…

Continue Reading

Friday Oct 01, 2021 - 2:58 pm

InvestorNewsBreaks – Brain Scientific Inc.’s (BRSF) Devices Addressing COVID, Research-Related Challenges in Neurological Market

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, has solved issues related to offering neurological services during COVID. The new surge in the Delta variant highlights two problems in hospitals and the neurological market: staff shortages and contamination. “When it comes to neurological services during COVID, Brain Scientific has solved these issues with its two FDA-cleared EEG technologies —…

Continue Reading

Tuesday Sep 28, 2021 - 1:17 pm

InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Initiates Pilot Program with Four 20 Pharma in Germany

RYAH Group (CSE: RYAH) today announced that it has completed an initial shipment of its proprietary RYAH Smart Dry Herb Inhalers for use in a pilot study to be conducted by Four 20 Pharma GmbH, a leading manufacturer, wholesaler and importer of medical cannabis and medical devices. The study is being conducted in preparation for a wider distribution strategy for the RYAH Smart Dry Herb…

Continue Reading

Monday Sep 27, 2021 - 1:08 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Eyes Commercial Plans to Become B2B Wholesale Supplier of Rare Cannabinoids

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company based in British Columbia, Canada, is focused on advancing a pipeline of cannabinoid-based pharmaceutical drug candidates. The company is developing a proprietary cannabinoid synthesis manufacturing system known as IntegraSyn(TM), which is designed to advance rare and lesser-known cannabinoid production to commercial levels. A recent article discussing this quotes InMed CEO Eric A. Adams. “The next key milestone is…

Continue Reading

Monday Sep 27, 2021 - 11:58 am

InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Working to Bring Psychedelic Treatments Closer to the People

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is contributing to the ongoing conversation around the use of psychedelics in the field of medicine, thereby stamping its position as a leader in the psychedelic renaissance. This follows efforts by the scientific community in the 21st century to prove the potential of psychedelics to rewire or repair circuits in the brain. Specifically, Tryp is bringing light to psilocybin…

Continue Reading

Friday Sep 24, 2021 - 2:06 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Enhancing Performance of Antiviral Drugs, CBD

Lexaria Bioscience Corp. (NASDAQ: LEXX) is making significant progress in advancing its patented DehydraTECH(TM) drug delivery technology. Lexaria recently reviewed its successful 2021 antiviral drug program. “The company has progressed significantly in evidencing that DehydraTECH can sufficiently enhance the usable fraction of known antiviral drugs that reach the bloodstream to safely and more effectively do what they are designed to accomplish,” reads a recent article.…

Continue Reading

Friday Sep 24, 2021 - 1:40 pm

InvestorNewsBreaks – AnPac Bio-Medical Science Co. Ltd.’s (NASDAQ: ANPC) CDA Technology Detects Risk of Over 25 Different Cancer Types

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, is a recognized innovator and leader in the field of early cancer screening and detection. Its core product and proven revenue generator, the pioneering Cancer Differentiation Analysis (“CDA”) platform, offers novel capabilities by looking for signals to help it assess the risk of cancer occurring before a tumor has developed.…

Continue Reading

Thursday Sep 23, 2021 - 2:31 pm

InvestorNewsBreaks – Brain Scientific Inc.’s (BRSF) Proprietary Brain Diagnostics Devices Positioned to Profoundly Shift EEG Market

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, is leveraging artificial intelligence (“AI”) and machine learning (“ML”) to improve diagnostic capability using a database of biomarkers that collect data on both normal and abnormal brain information. Brain Scientific’s use of AI and ML is part of its overall strategy to penetrate the rapidly growing electroencephalogram (“EEG”) market. The strategy…

Continue Reading

Wednesday Sep 22, 2021 - 12:35 pm

InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) to Present at Wall Street Reporter’s ‘Next Super Stock’ Livestream Conference

RYAH Group (CSE: RYAH) today announced that its Chief Executive Officer Gregory Wagner will be presenting at Wall Street Reporter's "Next Super Stock" livestream conference on Thursday, Sept. 23, 2021. The online event is expected to give the investment community and existing shareholders an opportunity to interact in real time with Wagner and learn about the company and its operations. Wagner’s presentation is scheduled to…

Continue Reading

Wednesday Sep 22, 2021 - 11:25 am

InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces Submission of IND Application for Eating Disorders Clinical Trial

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, has submitted an Investigational New Drug ("IND") application to the U.S. Food and Drug Administration ("FDA"). The clinical trial is designed to evaluate the efficacy of TRYP’s clinical candidate, TRP-8802, for the treatment of patients with eating disorders. TRYP is working with Jennifer Miller, MD,…

Continue Reading

Wednesday Sep 22, 2021 - 10:32 am

InvestorNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) Completes Successful Lemon Pilot Tests in Spain with Leading Post-Harvest Service Provider

Save Foods (NASDAQ: SVFD), an agri-food-tech company focused on developing and selling eco-friendly products specifically designed to extend shelf life and ensure food safety of fresh fruits and vegetables, today announced that it successfully completed a series of lemon treatment pilot tests in Spain with a leading post-harvest service provider. Spain is the largest lemon exporter in the world and the leading European country in…

Continue Reading

Wednesday Sep 22, 2021 - 10:12 am

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Present at Benzinga Healthcare Small Cap Conference

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild to moderate obstructive sleep apnea (“OSA”), today announced that its chairman and CEO Kirk Huntsman and CFO Brad Amman will be presenting at the online Benzinga Healthcare Small Cap Conference at 2:20 pm ET on Wednesday, Sept. 29, 2021. The event is…

Continue Reading

Friday Sep 17, 2021 - 3:09 pm

InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Leveraging IoT Devices, AI Analytics to Provide Innovative Plant-Based Treatments

RYAH Group (CSE: RYAH), a connected device and big data and technology company, recently released a report outlining cannabis treatment options to address symptoms and conditions associated with HIV and AIDS. The report is based on information compiled by the RYAH Data Ecosystem, which enabled patients to submit data outlining symptoms they addressed with the use of cannabis, in addition to detailing specific cannabis strains…

Continue Reading

Friday Sep 17, 2021 - 11:36 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM), BayMedica Slated to Participate in Tribe Public Webinar

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has announced that its CEO Eric A. Adams will be a featured presenter at Tribe Public’s upcoming complimentary ZOOM presentation titled “Accelerating The Commercialization of Rare Cannabinoids.” The webinar is scheduled to begin on Sept. 21, 2021, at 11.30 a.m. ET. In addition to Adams, BayMedica Inc. cofounder Shane Johnson…

Continue Reading

Tuesday Sep 07, 2021 - 2:35 pm

InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Positioned as First Mover in Psychedelics Space

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) CEO Greg McKee was recently hosted by Oren Klaff on the Dealmaker Podcast. The interview, which illuminated Tryp Therapeutics’ operations and McKee’s personal story on how he ended up as the CEO, offered some great insights into the future of the psychedelics space, along with what ordinary people can do to take the industry to the next level. A…

Continue Reading

Friday Sep 03, 2021 - 2:44 pm

InvestorNewsBreaks – InnerScope Hearing Technologies Inc. (INND) to Be Featured in ‘New to the Street’ Broadcast

InnerScope Hearing Technologies (OTC: INND) will be featured in an upcoming segment of FMW Media’s “New to the Street” nationally syndicated show. The company will be one of eight featured on Sunday, Sept. 5, 2021, with the broadcast airing at 10 to 11 a.m. ET. The segment will include an interview with INND CEO Matthew Moore, who will inform viewers about the company’s emerging and…

Continue Reading

Thursday Sep 02, 2021 - 12:38 pm

InvestorNewsBreaks – Brain Scientific Inc.’s (BRSF) Expanded Vision for Neurology Telemedicine Combines Diagnostic Solutions, AI, ML, and Cloud-Based Infrastructure

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, has developed cost-effective and portable proprietary brain diagnostic solutions — the NeuroCap(TM) and NeuroEEG(TM) — that are positioned to disrupt the electroencephalogram (“EEG”) market. With nearly every U.S. state experiencing a neurologist shortfall and experts warning that access to high-level care and diagnosis is immediately required to reduce mental disability, improve…

Continue Reading

Wednesday Sep 01, 2021 - 11:12 am

InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Present at H.C. Wainwright Global Investment Conference

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, today announced that it will present at the H.C. Wainwright Annual Global Investment Conference. The event is slated to be held virtually on Sept. 13-15, 2021. Greg McKee, chairman and CEO of Tryp, will provide an overview of the company and…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).